Tizanidne Hydrochloride Capsule
Product Images NDC 67877-612

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 67877-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

Chemical structure diagram of Tizanidine hydrochloride, showing its molecular components and bonds including a chloro-substituted benzene ring fused with a thiazole and an imidazoline moiety.*

FDA Label Image

Tiz02 (Tiz02)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing. The chart compares 2 x 4 mg and 2 x 2 mg Tizanidine tablets and capsules, with and without food, depicting their concentration profiles up to 24 hours post-dose.*

FDA Label Image

Tiz03 (Tiz03)

Line graph depicting improvement in Ashworth Score over 6 hours post-dose. It compares three groups receiving placebo, 8 mg tizanidine, and 16 mg tizanidine, showing greater improvement with higher tizanidine doses and a peak effect around 2 hours post-dose.*

FDA Label Image

Tiz04 (Tiz04)

A line plot with error bars showing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Two groups are compared: tizanidine (mean dose 28.8 mg) with scores improving (negative values) and placebo with scores near zero or slightly positive. The y-axis measures improvement in Ashworth Score, ranging from -6 to 2.*

FDA Label Image

Tiz05new (Tiz05new)

Tizanidine Hydrochloride Capsules 2 mg label displaying dosage form as capsules and package size of 150 capsules. The label includes a warning that the capsules are not interchangeable with tizanidine or Zanaflex tablets. Labeler is Ascend Laboratories, LLC with manufacturing by Alkem Laboratories Ltd., India. Storage instructions and trademark information for Zanaflex are noted. The label shows an NDC code 67877-610-15 and barcodes.*

FDA Label Image

Tiz06new (Tiz06new)

Packaging label for Tizanidine Hydrochloride Capsules 2 mg by Ascend Laboratories, LLC. The label states the capsules come in a bottle of 10 units and includes a warning that these capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. The label also provides storage instructions and manufacturer information for Alkem Laboratories Ltd., Mumbai, India, and distributor information for Ascend Laboratories, Parsippany, NJ.*

FDA Label Image

Tiz07 (Tiz07)

Label for Tizanidine Hydrochloride Capsule 2 mg (base), a prescription oral capsule. The label states it is manufactured for Ascend Laboratories, LLC and made in India. The label includes lot and expiration fields and a barcode.*

FDA Label Image

Tiz08new (Tiz08new)

Label for Tizanidine Hydrochloride Capsules 4 mg by Ascend Laboratories, LLC. The label shows the product name, strength 4 mg, dosage form capsules, and package count of 150 capsules. It includes a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets, storage instructions, and manufacturer information from Alkem Laboratories Ltd., Mumbai, India. There is a barcode and additional label printing instructions.*

FDA Label Image

Tiz09new (Tiz09new)

Packaging label for Tizanidine Hydrochloride Capsules 4 mg by Ascend Laboratories, LLC. The carton contains 10 capsules in unit dose form. The label includes a caution that these capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, Parsippany, NJ.*

FDA Label Image

Tiz10 (Tiz10)

Label for Tizanidine Hydrochloride Capsule 4 mg (base) manufactured for Ascend Laboratories, LLC. The label includes dosage strength, Rx only designation, manufacturing origin as India, a barcode, and placeholders for lot number and expiration date.*

FDA Label Image

Tiz11new (Tiz11new)

Label for Tizanidine Hydrochloride Capsules 6 mg, oral dosage form, containing 150 capsules per container. The label states the product is Rx only and includes storage instructions, manufacturer (Alkem Laboratories Ltd., India), and distributor information (Ascend Laboratories, LLC). A red warning highlights non-interchangeability with tizanidine tablets or Zanaflex tablets. Barcode and lot/expiration date placeholders with 2D code are also visible.*

FDA Label Image

Tiz12new (Tiz12new)

Packaging label for Tizanidine Hydrochloride Capsules 6 mg by Ascend Laboratories, LLC. The label includes the NDC 67877-612-33 and states the product contains 10 capsules (1 x 10 unit dose). It features a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Manufacturer: Alkem Laboratories Ltd., India; Distributed by Ascend Laboratories, LLC, Parsippany, NJ.*

FDA Label Image

Tiz13 (Tiz13)

Label for Tizanidine Hydrochloride capsule, 6 mg (base), manufactured for Ascend Laboratories, LLC. The label includes 'Rx Only' designation, lot number placeholder, expiration date placeholder, and a barcode. The product is stated to be made in India, and the label features a peel here indication on the corner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.